Evidence map›Paper›PMID 28962634›Full record

ArticleTrials2017

Clinical features of Parkinson's disease patients are associated with therapeutic misconception and willingness to participate in clinical trials.

Emmi Reijula, Anna-Maija Pietilä, Arja Halkoaho, Tuomas Selander, Kirsti Martikainen, Reetta Kälviäinen, Tapani Keränen

Abstract read
In one paragraph

Article in Trials, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Comparison of Patient and Expert Perceptions of the Attainment of Research Milestones in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2021
    Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emmi ReijulaUniversity of Eastern Finland, Faculty of Health Sciences, Kuopio, Finland. emmi.reijula@gmail.com.
Anna-Maija PietiläUniversity of Eastern Finland, Faculty of Health Sciences, Kuopio, Finland.
Arja HalkoahoKuopio University Hospital, Science Service Center, PO Box 100, 70029, Kuopio, Finland.
Tuomas SelanderKuopio University Hospital, Science Service Center, PO Box 100, 70029, Kuopio, Finland.
Kirsti MartikainenThe Finnish Parkinson Association, Turku, Finland.
Reetta KälviäinenNeuroCenter, Kuopio University Hospital, Kuopio, Finland.
Tapani KeränenKuopio University Hospital, Science Service Center, PO Box 100, 70029, Kuopio, Finland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundClinical trials (CTs) are the "gold standard" to ensure the development of new effective treatments in medicine. A study was conducted to assess knowledge of, and attitudes toward, clinical trials among patients with Parkinson's disease (PD), along with factors that motivate them to participate.

methodsA 50-item questionnaire on the views of patients with PD about CTs was developed. It included statements that the respondents assessed on a Likert scale from 1 ("strongly disagree") to 5 ("strongly agree"). The questionnaire was mailed to a random sample (n = 2000) of members of the patient organization the Finnish Parkinson Association. In all, 708 response forms were returned, of which 681 were accepted after exclusion (a 34% response rate).

resultsIn general, attitudes of patients with PD toward CTs were positive. Older subjects and patients with lower education levels had inadequate knowledge of general issues related to CTs. Older age, low level of education, and lower number of PD medications were significant predictors for failure to understand the nature and purpose of clinical research. Additionally, significant positive correlation was found between education level and willingness to participate in CTs.

conclusionsPatients with PD have important gaps in their knowledge of methodological issues associated with CTs. The oldest subjects and those with a low level of education have the greatest information needs. Investigators should pay more attention to ensuring the comprehensibility of the information provided to potential CT participants.

Indexed as

Health Knowledge, Attitudes, PracticePatient SelectionAgedAged, 80 and overAge FactorsAntiparkinson AgentsClinical Trials as TopicComprehensionConsumer Health InformationEducational StatusFinlandHumansMiddle AgedMotivationParkinson DiseaseResearch DesignAntiparkinson AgentsClinical trialsParkinson’s diseaseTherapeutic misconception

Identifiers

PMID28962634
PMCPMC5622447

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.